Douglas D. Cary, R.Ph., M.B.A.
President, CEO and Director
• Developed AddVantage® & Patient-Controlled Analgesia® at Abbott (cumulative sales over $1B).

Carl C. Schwan, M.B.A., C.P.A.
Executive VP, Chief Financial Officer and Director
• Completed IPOs at BioReliance and North American Vaccine.

Andrew R. Menard, J.D.
Vice President and Director
• Negotiated several pharmaceutical licensing agreements (e.g., Pepcid Complete® with J&J).

Lewellys F. Barker, M.D., M.P.H.
Executive VP, Chief Scientific Officer and Director
• Led the development of diagnostic products for testing blood for hepatitis and HIV at the American Red Cross and FDA.

Stephen D. Cary, M.B.A.
Director
• Launched GlaxoSmithKline’s smoking cessation product, Zyban®.

Lester M. Crawford, D.V.M., Ph.D.
Director
• Former Commissioner of the FDA and Senior Counsel at Policy Directions Inc., a Washington, D.C. based government relations/strategic government communications firm.